TEVOGEN BIO Revenue and Competitors

Metuchen, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TEVOGEN BIO's estimated annual revenue is currently $2M per year.(i)
  • TEVOGEN BIO's estimated revenue per employee is $77,500

Employee Data

  • TEVOGEN BIO has 26 Employees.(i)
  • TEVOGEN BIO grew their employee count by -4% last year.

TEVOGEN BIO's People

NameTitleEmail/Phone
1
CIO & Head Tevogen AIReveal Email/Phone
2
Head Investor Relations and Corporate DevelopmentReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
Chief Technical OfficerReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Chief Information OfficerReveal Email/Phone
9
Senior Manager, Preclinical ResearchReveal Email/Phone
10
R&D and Laboratory Services CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.2M27N/AN/AN/A
Add Company

What Is TEVOGEN BIO?

Tevogen Bio brings together an experienced team of scientists, public health experts, physicians, and life sciences professionals with the goal of advancing global health by investigating the potential of scalable therapies and vaccines. The company's mission is to leverage its proprietary immunotherapy platform to develop investigational therapies in oncology, viral vaccines and harnessing its targeted T cell therapy to develop investigational products to treat viral infections such as COVID-19 and Influenza.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$2M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TEVOGEN BIO News

2022-04-06 - Tevogen Bio Appoints Chief Technology Officer & Global ...

Stephen Chen joins Tevogen Bio as Chief Technical Officer and Sadiq Khan joins as Global Commercial Lead. Image courtesy of Business Wire.

2022-04-06 - Tevogen Bio Expands Executive Leadership Team to ...

Tevogen Bio is driven by a team of distinguished scientists and highly experienced biopharmaceutical leaders who have successfully developed and...

2022-03-22 - Tevogen Bio receives new investment for precision T cell ...

Tevogen says its tech is designed to allow development of unmodified T cell therapeutics from a single donor to treat hundreds of patients...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M28-20%N/A
#2
$8.5M303%N/A
#3
$3.1M3015%N/A
#4
N/A3413%N/A
#5
$4.9M3410%N/A